For many, the emergence of medications like semaglutide and tirzepatide has opened new pathways, offering significant support in managing weight and blood sugar
4 Research has shown that ALCAR can improve cognitive function, particularly in people who are starting to experience age-related decline
(Zepbound is a registered trademark of Eli Lilly, and Wegovy is a registered trademark of Novo Nordisk, and we claim no affiliation with or endorsement by either company.) Frequently asked questions about the starter program The starter program is available to anyone who has not taken a GLP-1 or GLP-1 medication in the past two months, as well as those transferring to NiceRx on one of the two lowest doses
In addition to weight loss, other Zepbound health benefits include improved blood sugar control and cardiovascular health, such as lower blood pressure and cholesterol levels
In the SURMOUNT trials evaluating tirzepatide for chronic weight management, participants lost an average of 15% to 22% of their body weight over 72 weeks, depending on the dose
Ongoing care includes regular check-ins with your clinician to monitor progress, adjust dosing, and address any side effects
